Surface localization of Pseudomonas aeruginosa outer membrane porin protein F by using monoclonal antibodies

Related Experiment Videos

Insights

Monoclonal antibodies targeting Pseudomonas aeruginosa porin protein F were developed. These antibodies confirmed protein F

Area of Science:

  • Microbiology
  • Immunology
  • Bacterial Pathogenesis

Background:

  • Pseudomonas aeruginosa is an opportunistic pathogen, frequently causing infections in cystic fibrosis patients.
  • Outer membrane proteins, such as porin protein F, are crucial for bacterial structure and interaction with the host.
  • Understanding the surface localization and antigenicity of P. aeruginosa outer membrane proteins is vital for developing targeted therapies.

Purpose of the Study:

  • To isolate and characterize monoclonal antibodies specific for Pseudomonas aeruginosa porin protein F.
  • To investigate the cell surface localization of antigenic sites on porin protein F.
  • To assess the utility of these antibodies in identifying P. aeruginosa strains.

Main Methods:

  • Hybridoma technology was employed to generate monoclonal antibodies against porin protein F.
  • Immunofluorescence techniques were used to determine the cell surface localization of antigenic sites.
  • Antibody reactivity was tested against various P. aeruginosa strains, including serotypes and clinical isolates.

Main Results:

  • Highly specific monoclonal antibodies against porin protein F were successfully isolated.
  • These antibodies recognized protein F in outer membranes from 17 P. aeruginosa serotypes and 15 cystic fibrosis isolates.
  • Indirect immunofluorescence confirmed the cell surface localization of antigenic sites on protein F, with no reactivity on a protein F-deficient mutant.

Conclusions:

  • Monoclonal antibodies provide a specific tool for detecting Pseudomonas aeruginosa porin protein F.
  • Porin protein F possesses cell surface-exposed antigenic sites, making it a potential target for immunodiagnostics or therapeutics.
  • The developed antibodies demonstrate broad reactivity against diverse P. aeruginosa strains, including clinically relevant isolates.

Related Concept Videos